Status:
COMPLETED
Determining Beta-hCG Levels in Patients Through Alternative Sample Types
Lead Sponsor:
Simple HealthKit
Collaborating Sponsors:
Planned Parenthood Federation of America
Planned Parenthood Great Northwest, Hawai'I, Alaska, Indiana, Kentucky
Conditions:
Pregnancy Related
Abortion
Eligibility:
FEMALE
18+ years
Brief Summary
This study is to determine if there is any quantifiable correlation between serum beta hCG and dried blood spot (DBS) beta hCG levels. This data will be used to develop a less invasive collection meth...
Detailed Description
A cohort of 40 individuals at various stages of pregnancy or medical abortion will be recruited for the study. Each participant will provide biospecimens that include the following: serum, saliva, uri...
Eligibility Criteria
Inclusion
- Are at least 18 years old
- Have not taken antibiotics in the last 21 days
- Are here for services related to a current or recent pregnancy
- Agree to provide all required samples
- Have not previously participated in this study
Exclusion
- Are under18 years old
- Have taken antibiotics in the last 21 days
- Are not here for services related to a current or recent pregnancy
- Disagree or unable to provide all required samples
- Have previously participated in this study
Key Trial Info
Start Date :
October 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 23 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06178224
Start Date
October 11 2022
End Date
June 23 2023
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Planned Parenthood of the Great Northwest, Hawai'i, Alaska, Indiana and Kentucky
Tacoma, Washington, United States, 98405